Stacy Moulder

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.

View Article and Find Full Text PDF

September 2020

Response of Brain Metastases From -Mutant Breast Cancer to Alpelisib.

Authors:

Felipe Batalini Stacy L Moulder Eric P Winer Hope S Rugo Nancy U Lin Gerburg M Wulf

JCO Precis Oncol 2020 27;4. Epub 2020 May 27.

Beth Israel Deaconess Medical Center, Boston, MA.

View Article and Find Full Text PDF

May 2020

Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).

Breast Cancer Res Treat 2020 Sep 13. Epub 2020 Sep 13.

Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1350, Houston, TX, 77030, USA.

View Article and Find Full Text PDF

September 2020

Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients.

Authors:

Rosalind P Candelaria Beatriz E Adrada Kenneth Hess Lumarie Santiago Deanna L Lane Alastair M Thompson Stacy L Moulder Monica L Huang Elsa M Arribas Gaiane M Rauch Jessica W T Leung W Fraser Symmans Vicente Valero Elizabeth E Ravenberg Jason B White Wei Tse Yang

Eur J Radiol 2020 Sep 10;130:109170. Epub 2020 Jul 10.

Breast Imaging Department, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article and Find Full Text PDF

September 2020

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

Authors:

Douglas Yee Angela M DeMichele Christina Yau Claudine Isaacs W Fraser Symmans Kathy S Albain Yunn-Yi Chen Gregor Krings Shi Wei Shuko Harada Brian Datnow Oluwole Fadare Molly Klein Stefan Pambuccian Beiyun Chen Kathi Adamson Sharon Sams Paulette Mhawech-Fauceglia Anthony Magliocco Mike Feldman Mara Rendi Husain Sattar Jay Zeck Idris T Ocal Ossama Tawfik Lauren Grasso LeBeau Sunati Sahoo Tuyethoa Vinh A Jo Chien Andres Forero-Torres Erica Stringer-Reasor Anne M Wallace Lajos Pusztai Judy C Boughey Erin D Ellis Anthony D Elias Janice Lu Julie E Lang Hyo S Han Amy S Clark Rita Nanda Donald W Northfelt Qamar J Khan Rebecca K Viscusi David M Euhus Kirsten K Edmiston Stephen Y Chui Kathleen Kemmer John W Park Minetta C Liu Olufunmilayo Olopade Brian Leyland-Jones Debasish Tripathy Stacy L Moulder Hope S Rugo Richard Schwab Shelly Lo Teresa Helsten Heather Beckwith Patricia Haugen Nola M Hylton Laura J Van't Veer Jane Perlmutter Michelle E Melisko Amy Wilson Garry Peterson Adam L Asare Meredith B Buxton Melissa Paoloni Julia L Clennell Gillian L Hirst Ruby Singhrao Katherine Steeg Jeffrey B Matthews Smita M Asare Ashish Sanil Scott M Berry Laura J Esserman Donald A Berry

JAMA Oncol 2020 Sep;6(9):1355-1362

Berry Consultants, LLC, Austin, Texas.

View Article and Find Full Text PDF

September 2020

Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors.

Authors:

Hua Guo Qingqing Ding Yun Gong Michael Z Gilcrease Min Zhao Jun Zhao Dawen Sui Yun Wu Hui Chen Hui Liu Jinxia Zhang Erika Resetkova Stacy L Moulder Wei-Lien Wang Lei Huo

Breast Cancer Res 2020 06 23;22(1):69. Epub 2020 Jun 23.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Unit 85, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article and Find Full Text PDF

June 2020

Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer.

Authors:

Yu-Yi Chu Clinton Yam Mei-Kuang Chen Li-Chuan Chan Min Xiao Yong-Kun Wei Hirohito Yamaguchi Pei-Chih Lee Ye Han Lei Nie Xian Sun Stacy L Moulder Kenneth R Hess Bin Wang Jennifer L Hsu Gabriel N Hortobagyi Jennifer Litton Jeffrey T Chang Mien-Chie Hung

Am J Cancer Res 2020 1;10(2):648-661. Epub 2020 Feb 1.

Graduate Institute of Biomedical Sciences, Research Center for Cancer Biology, Center for Molecular Medicine, China Medical University Taichung 404, Taiwan.

View Article and Find Full Text PDF

February 2020

Phase 1 Dose Escalation Study of the Allosteric AKT Inhibitor BAY 1125976 in Advanced Solid Cancer-Lack of Association between Activating AKT Mutation and AKT Inhibition-Derived Efficacy.

Authors:

Andreas Schneeweiss Dagmar Hess Markus Joerger Andrea Varga Stacy Moulder Apostolia M Tsimberidou Cynthia Ma Sara A Hurvitz Christine Rentzsch Marion Rudolph Silke Thiele Oliver Boix Gary Wilkinson Eleni Lagkadinou Matthias Ocker

Cancers (Basel) 2019 Dec 10;11(12). Epub 2019 Dec 10.

Bayer AG, 13353 Berlin, Germany.

View Article and Find Full Text PDF

December 2019

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline Pathogenic Variant.

Authors:

Jennifer K Litton Marion E Scoggins Kenneth R Hess Beatriz E Adrada Rashmi K Murthy Senthil Damodaran Sarah M DeSnyder Abenaa M Brewster Carlos H Barcenas Vicente Valero Gary J Whitman Jill Schwartz-Gomez Elizabeth A Mittendorf Alastair M Thompson Thorunn Helgason Nuhad Ibrahim Helen Piwnica-Worms Stacy L Moulder Banu K Arun

J Clin Oncol 2020 02 28;38(5):388-394. Epub 2019 Aug 28.

The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF

February 2020

Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy.

Cancers (Basel) 2019 May 24;11(5). Epub 2019 May 24.

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF

May 2019

Debating the Optimal Approach to Nodal Management After Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.

Authors:

Stacey Carter Heather Neuman Eleftherios P Mamounas Isabelle Bedrosian Stacy Moulder Alberto J Montero Reshma Jagsi

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:42-48. Epub 2019 May 17.

7 Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI.

View Article and Find Full Text PDF

January 2019

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.

Br J Cancer 2019 06 17;120(12):1105-1112. Epub 2019 May 17.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

June 2019

Imaging features of triple-negative breast cancers according to androgen receptor status.

Authors:

Rosalind P Candelaria Beatriz E Adrada Wei Wei Alastair M Thompson Lumarie Santiago Deanna L Lane Monica L Huang Elsa M Arribas Gaiane M Rauch W Fraser Symmans Michael Z Gilcrease Lei Huo Bora Lim Naoto T Ueno Stacy L Moulder Wei Tse Yang

Eur J Radiol 2019 May 21;114:167-174. Epub 2019 Mar 21.

Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address:

View Article and Find Full Text PDF

May 2019